{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T13:31:12Z","timestamp":1778592672533,"version":"3.51.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T00:00:00Z","timestamp":1635292800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T00:00:00Z","timestamp":1635292800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100021171","name":"Guangdong Basic and Applied Basic Research Foundation","doi-asserted-by":"crossref","award":["2019A1515110069"],"award-info":[{"award-number":["2019A1515110069"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Special project of Shenzhen Sustainable Development Science and Technology","award":["KCXFZ202002011010232"],"award-info":[{"award-number":["KCXFZ202002011010232"]}]},{"name":"Shenzhen Free Exploration project of Basic Research","award":["JCYJ20180306173333907"],"award-info":[{"award-number":["JCYJ20180306173333907"]}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2016A030308007"],"award-info":[{"award-number":["2016A030308007"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["NSFC31900136"],"award-info":[{"award-number":["NSFC31900136"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Increasing studies demonstrated that oncolytic activities of oHSV-1 are limited to the capacity of virus replicating in tumors. In order to potentiate the oHSV-1 oncolytic activity and expand the application of oHSV-1 treatment in multiple types of tumors, it is critical to explore the potential factors or mechanisms mediating tumor resistance to oHSV-1 infection. Here we evaluated the levels of oHSV-1 multiplication in various tumor cell lines and showed that glioblastoma cell line A172 had the lowest virus yields but intrinsically accumulated the highest levels of Mx2 protein. Subsequently we demonstrated that genetic depletion of Mx2 specifically enhanced oHSV-1 productive replication in A172 cells through promoting the nuclear translocation of uncoated viral genomic DNA and down-regulating innate antiviral response. In the further investigation, we found that Mx2 knockdown could alter the intrinsic mRNA accumulation of diverse sets innate immune genes in A172 cells, in particular DHX36 and MyD88. Mx2 depletion led to a decrease in mRNA levels of MyD88 and DHX36 in A172 cells and MyD88\/DHX36 knockdown increased virus yield in A172 cells and decreased the production of IFN\u03b1, activation of IRF3 activity and NF-\u03baB signaling in A172 cells. This shed new lights on understanding the roles of some intrinsic antiviral genes in oHSV-1 resistance, facilitating to offer potential targets to improve oHSV-1 oncolytic efficacy and develop candidates of biomarkers to predict the efficiency of oHSV-1 multiplication in tumors.<\/jats:p>","DOI":"10.1038\/s41598-021-00691-y","type":"journal-article","created":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T10:04:13Z","timestamp":1635329053000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["High accumulation of Mx2 renders limited multiplication of oncolytic herpes simplex virus-1 in human tumor cells"],"prefix":"10.1038","volume":"11","author":[{"given":"Yong","family":"Ren","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meiling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangxian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongmei","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grace Guoying","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei-Gen","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenmin","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,10,27]]},"reference":[{"key":"691_CR1","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1093\/annonc\/mdw194","volume":"27","author":"RS Coffin","year":"2016","unstructured":"Coffin, R. S. Oncolytic immunotherapy: An emerging new modality for the treatment of cancer. Ann. Oncol. 27, 1805\u20131808. https:\/\/doi.org\/10.1093\/annonc\/mdw194 (2016).","journal-title":"Ann. Oncol."},{"key":"691_CR2","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/s41573-019-0029-0","volume":"18","author":"K Harrington","year":"2019","unstructured":"Harrington, K., Freeman, D. J., Kelly, B., Harper, J. & Soria, J. C. Optimizing oncolytic virotherapy in cancer treatment. Nat. Rev. Drug Discov. 18, 689\u2013706. https:\/\/doi.org\/10.1038\/s41573-019-0029-0 (2019).","journal-title":"Nat. Rev. Drug Discov."},{"key":"691_CR3","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/978-94-017-7555-7_5","volume":"909","author":"A Tsun","year":"2016","unstructured":"Tsun, A., Miao, X. N., Wang, C. M. & Yu, D. C. Oncolytic immunotherapy for treatment of cancer. Adv. Exp. Med. Biol. 909, 241\u2013283. https:\/\/doi.org\/10.1007\/978-94-017-7555-7_5 (2016).","journal-title":"Adv. Exp. Med. Biol."},{"key":"691_CR4","doi-asserted-by":"publisher","first-page":"129","DOI":"10.2217\/cns.12.42","volume":"2","author":"R Kanai","year":"2013","unstructured":"Kanai, R. & Rabkin, S. D. Combinatorial strategies for oncolytic herpes simplex virus therapy of brain tumors. CNS Oncol. 2, 129\u2013142. https:\/\/doi.org\/10.2217\/cns.12.42 (2013).","journal-title":"CNS Oncol."},{"key":"691_CR5","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/mt.2012.175","volume":"21","author":"K Tamura","year":"2013","unstructured":"Tamura, K. et al. Multimechanistic tumor targeted oncolytic virus overcomes resistance in brain tumors. Mol. Ther. 21, 68\u201377. https:\/\/doi.org\/10.1038\/mt.2012.175 (2013).","journal-title":"Mol. Ther."},{"key":"691_CR6","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/gt.2015.105","volume":"23","author":"PY Wang","year":"2016","unstructured":"Wang, P. Y. et al. Neuroblastomas vary widely in their sensitivities to herpes simplex virotherapy unrelated to virus receptors and susceptibility. Gene Ther. 23, 135\u2013143. https:\/\/doi.org\/10.1038\/gt.2015.105 (2016).","journal-title":"Gene Ther."},{"key":"691_CR7","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1038\/s41467-018-04379-2","volume":"9","author":"M Crameri","year":"2018","unstructured":"Crameri, M. et al. MxB is an interferon-induced restriction factor of human herpesviruses. Nat. Commun. 9, 1980. https:\/\/doi.org\/10.1038\/s41467-018-04379-2 (2018).","journal-title":"Nat. Commun."},{"key":"691_CR8","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nature12542","volume":"502","author":"C Goujon","year":"2013","unstructured":"Goujon, C. et al. Human MX2 is an interferon-induced post-entry inhibitor of HIV-1 infection. Nature 502, 559\u2013562. https:\/\/doi.org\/10.1038\/nature12542 (2013).","journal-title":"Nature"},{"key":"691_CR9","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00709-18","author":"P Staeheli","year":"2018","unstructured":"Staeheli, P. & Haller, O. Human MX2\/MxB: A potent interferon-induced postentry inhibitor of herpesviruses and HIV-1. J. Virol. https:\/\/doi.org\/10.1128\/JVI.00709-18 (2018).","journal-title":"J. Virol."},{"key":"691_CR10","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.virol.2018.07.017","volume":"522","author":"AA Jaguva Vasudevan","year":"2018","unstructured":"Jaguva Vasudevan, A. A. et al. MXB inhibits murine cytomegalovirus. Virology 522, 158\u2013167. https:\/\/doi.org\/10.1016\/j.virol.2018.07.017 (2018).","journal-title":"Virology"},{"key":"691_CR11","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.jhep.2019.12.009","volume":"72","author":"YX Wang","year":"2020","unstructured":"Wang, Y. X. et al. Interferon-inducible MX2 is a host restriction factor of hepatitis B virus replication. J. Hepatol. 72, 865\u2013876. https:\/\/doi.org\/10.1016\/j.jhep.2019.12.009 (2020).","journal-title":"J. Hepatol."},{"key":"691_CR12","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01285-18","author":"DR Yi","year":"2019","unstructured":"Yi, D. R. et al. Human MxB inhibits the replication of hepatitis C virus. J. Virol. https:\/\/doi.org\/10.1128\/JVI.01285-18 (2019).","journal-title":"J. Virol."},{"key":"691_CR13","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.tim.2014.12.003","volume":"23","author":"O Haller","year":"2015","unstructured":"Haller, O., Staeheli, P., Schwemmle, M. & Kochs, G. Mx GTPases: Dynamin-like antiviral machines of innate immunity. Trends Microbiol. 23, 154\u2013163. https:\/\/doi.org\/10.1016\/j.tim.2014.12.003 (2015).","journal-title":"Trends Microbiol."},{"key":"691_CR14","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01056-18","author":"M Schilling","year":"2018","unstructured":"Schilling, M. et al. Human MxB protein is a pan-herpesvirus restriction factor. J. Virol. https:\/\/doi.org\/10.1128\/JVI.01056-18 (2018).","journal-title":"J. Virol."},{"key":"691_CR15","first-page":"1","volume":"5","author":"RB Yan","year":"2019","unstructured":"Yan, R. B. et al. Enhancement of oncolytic activity of oHSV expressing IL-12 and anti PD-1 antibody by concurrent administration of exosomes carrying CTLA-4 miRNA. Immunotherapy 5, 1\u201310 (2019).","journal-title":"Immunotherapy"},{"key":"691_CR16","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12977-020-00524-2","volume":"17","author":"L Xie","year":"2020","unstructured":"Xie, L. et al. MxB impedes the NUP358-mediated HIV-1 pre-integration complex nuclear import and viral replication cooperatively with CPSF6. Retrovirology 17, 16. https:\/\/doi.org\/10.1186\/s12977-020-00524-2 (2020).","journal-title":"Retrovirology"},{"key":"691_CR17","doi-asserted-by":"publisher","first-page":"8957","DOI":"10.1073\/pnas.0403167101","volume":"101","author":"MC King","year":"2004","unstructured":"King, M. C., Raposo, G. & Lemmon, M. A. Inhibition of nuclear import and cell-cycle progression by mutated forms of the dynamin-like GTPase MxB. Proc Natl Acad Sci USA 101, 8957\u20138962. https:\/\/doi.org\/10.1073\/pnas.0403167101 (2004).","journal-title":"Proc Natl Acad Sci USA"},{"key":"691_CR18","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.chom.2013.09.004","volume":"14","author":"IH Wang","year":"2013","unstructured":"Wang, I. H. et al. Tracking viral genomes in host cells at single-molecule resolution. Cell Host Microbe 14, 468\u2013480. https:\/\/doi.org\/10.1016\/j.chom.2013.09.004 (2013).","journal-title":"Cell Host Microbe"},{"key":"691_CR19","doi-asserted-by":"publisher","first-page":"481","DOI":"10.3390\/molecules24030481","volume":"24","author":"TG M\u00fcller","year":"2019","unstructured":"M\u00fcller, T. G., Sakin, V. & M\u00fcller, B. A spotlight on viruses-application of click chemistry to visualize virus\u2013cell interactions. Molecules 24, 481. https:\/\/doi.org\/10.3390\/molecules24030481 (2019).","journal-title":"Molecules"},{"key":"691_CR20","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1146\/annurev.cellbio.16.1.627","volume":"16","author":"GR Whittaker","year":"2000","unstructured":"Whittaker, G. R., Kann, M. & Helenius, A. Viral entry into the nucleus. Annu. Rev. Cell Dev. Biol. 16, 627\u2013651. https:\/\/doi.org\/10.1146\/annurev.cellbio.16.1.627 (2000).","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"691_CR21","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/3-540-26764-6_4","volume":"285","author":"UF Greber","year":"2005","unstructured":"Greber, U. F. & Fornerod, M. Nuclear import in viral infections. Curr. Top. Microbiol. Immunol. 285, 109\u2013138. https:\/\/doi.org\/10.1007\/3-540-26764-6_4 (2005).","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"691_CR22","doi-asserted-by":"publisher","first-page":"e1006721","DOI":"10.1371\/journal.ppat.1006721","volume":"13","author":"E Sekine","year":"2017","unstructured":"Sekine, E., Schmidt, N., Gaboriau, D. & O\u2019Hare, P. Spatiotemporal dynamics of HSV genome nuclear entry and compaction state transitions using bioorthogonal chemistry and super-resolution microscopy. PLoS Pathog. 13, e1006721. https:\/\/doi.org\/10.1371\/journal.ppat.1006721 (2017).","journal-title":"PLoS Pathog."},{"key":"691_CR23","doi-asserted-by":"publisher","first-page":"8028","DOI":"10.1128\/jvi.74.17.8028-8037.2000","volume":"74","author":"JP Castillo","year":"2000","unstructured":"Castillo, J. P., Yurochko, A. D. & Kowalik, T. F. Role of human cytomegalovirus immediate-early proteins in cell growth control. J. Virol. 74, 8028\u20138037. https:\/\/doi.org\/10.1128\/jvi.74.17.8028-8037.2000 (2000).","journal-title":"J. Virol."},{"key":"691_CR24","doi-asserted-by":"publisher","first-page":"290","DOI":"10.3390\/v8100290","volume":"8","author":"T Komatsu","year":"2016","unstructured":"Komatsu, T., Nagata, K. & Wodrich, H. The role of nuclear antiviral factors against invading DNA viruses: The immediate fate of incoming viral genomes. Viruses 8, 290. https:\/\/doi.org\/10.3390\/v8100290 (2016).","journal-title":"Viruses"},{"key":"691_CR25","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1034\/j.1600-0854.2003.00114.x","volume":"4","author":"UF Greber","year":"2003","unstructured":"Greber, U. F. & Fassati, A. Nuclear import of viral DNA genomes. Traffic 4, 136\u2013143. https:\/\/doi.org\/10.1034\/j.1600-0854.2003.00114.x (2003).","journal-title":"Traffic"},{"key":"691_CR26","doi-asserted-by":"publisher","first-page":"467","DOI":"10.3389\/fmicb.2015.00467","volume":"6","author":"N Fay","year":"2015","unstructured":"Fay, N. & Pant\u00e9, N. Nuclear entry of DNA viruses. Front. Microbiol. 6, 467. https:\/\/doi.org\/10.3389\/fmicb.2015.00467 (2015).","journal-title":"Front. Microbiol."},{"key":"691_CR27","doi-asserted-by":"publisher","first-page":"4475","DOI":"10.1128\/JVI.75.10.4475-4481.2001","volume":"75","author":"EK Flemington","year":"2001","unstructured":"Flemington, E. K. Herpesvirus lytic replication and the cell cycle: Arresting new developments. J. Virol. 75, 4475\u20134481. https:\/\/doi.org\/10.1128\/JVI.75.10.4475-4481.2001 (2001).","journal-title":"J. Virol."},{"key":"691_CR28","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1006\/viro.1999.0146","volume":"267","author":"B Song","year":"2000","unstructured":"Song, B., Liu, J. J., Yeh, K. C. & Knipe, D. M. Herpes simplex virus infection blocks events in the G1 phase of the cell cycle. Virology 267, 326\u2013334. https:\/\/doi.org\/10.1006\/viro.1999.0146 (2000).","journal-title":"Virology"},{"key":"691_CR29","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1016\/j.celrep.2019.10.009","volume":"29","author":"G Betancor","year":"2019","unstructured":"Betancor, G. et al. The GTPase domain of MX2 interacts with the HIV-1 capsid, enabling its short isoform to moderate antiviral restriction. Cell Rep. 29, 1923-1933.e1923. https:\/\/doi.org\/10.1016\/j.celrep.2019.10.009 (2019).","journal-title":"Cell Rep."},{"key":"691_CR30","doi-asserted-by":"publisher","DOI":"10.1007\/s12250-020-00249-8","author":"L Xie","year":"2020","unstructured":"Xie, L. et al. GTPase activity of MxB contributes to its nuclear location, interaction with nucleoporins and anti-HIV-1 activity. Virol. Sin. https:\/\/doi.org\/10.1007\/s12250-020-00249-8 (2020).","journal-title":"Virol. Sin."},{"key":"691_CR31","doi-asserted-by":"publisher","first-page":"e01005-19","DOI":"10.1128\/JVI.01005-19","volume":"93","author":"R Huang","year":"2019","unstructured":"Huang, R. et al. Herpes simplex virus 1 microRNA miR-H28 exported to uninfected cells in exosomes restricts cell-to-cell virus spread by inducing gamma interferon mRNA. J. Virol. 93, e01005-19. https:\/\/doi.org\/10.1128\/JVI.01005-19 (2019).","journal-title":"J. Virol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-00691-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-00691-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-00691-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T16:58:51Z","timestamp":1670086731000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-00691-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,27]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["691"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-00691-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,27]]},"assertion":[{"value":"23 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21227"}}